Published by National Institute for Health and Care Excellence (NICE), Scottish Intercollegiate Guidelines Network (SIGN) and Royal College of General Practitioners (RCGP) on Nov 3, 2022
Disclaimer
Sponsors
Contact
Abstract
Language
en-gb
PICOS
PICO 2.1
Population
Adults and children experiencing ongoing symptoms beyond the duration of acute COVID-19 illness (>4 weeks)
Intervention
Comparator
Outcomes
PICO 2.2
Population
Adults experiencing symptoms beyond the duration of acute COVID-19 illness (>4 weeks)
Intervention
Not applicable
Comparator
Not applicable
Outcomes
PICO 2.3
Population
Adults experiencing symptoms beyond the duration of acute COVID-
Intervention
Not applicable
Comparator
Not applicable
Outcomes
PICO 2.4
Population
Children experiencing ongoing symptoms beyond the duration of acute COVID-19 illness (>4 weeks)
Intervention
Not applicable
Comparator
Not applicable
Outcomes
PICO 2.5
Population
Children experiencing ongoing symptoms beyond the duration of acute COVID-19 illness (>4 weeks)
Intervention
Not applicable
Comparator
Not applicable
Outcomes
PICO 5.1
Population
Adults and children experiencing ongoing symptoms beyond the duration of acute COVID-19 illness (>4 weeks)
Intervention
Not applicable
Comparator
Not applicable
Outcomes
PICO 6.1
Population
People with history of COVID-19 infection after vaccination
Intervention
COVID-19 vaccination (any)
Comparator
No vaccination
Outcomes
PICO 6.2
Population
Adults and children who are experiencing new or ongoing symptoms: • 4-12 weeks from pre-vaccination onset of acute COVID-19 illness • 12 weeks from pre-vaccination onset of acute COVID-19 illness
Intervention
COVID-19 Vaccination
Comparator
No vaccination
Outcomes
